ELEVANCE HEALTH INC (ELV) Institutional Buying Activity

Institutional investors tracked by InsiderSet increased exposure to ELEVANCE HEALTH INC (ELV) during the quarter ended March 31, 2026 through a combination of new purchases and expanded existing positions disclosed in SEC Form 13F filings.

The largest institutional buyer of ELV during the latest reporting period was First Eagle U.S. Value, which increased its reported ELV position by approximately $32.03M based on quarter-end filing values. Several additional hedge funds and long-term asset managers also reported meaningful increases in ELV exposure during the quarter.

Institutional buying activity can provide insight into investor conviction, sector allocation trends, and smart money positioning toward ELEVANCE HEALTH INC (ELV). InsiderSet tracks quarterly accumulation trends, new institutional positions, ownership increases, and estimated performance of newly disclosed holdings using SEC filing data and recent market prices.

The investors highlighted on this page collectively added approximately $48.32M in reported ELV exposure during the latest filing period, reflecting continued institutional interest in ELEVANCE HEALTH INC's growth initiatives and strategic positioning.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2026First Eagle U.S. ValueBuy109,4174,132,291$1,209,728,290
Q1 2026Eagle Capital ManagementBuy44,5591,548,610$453,355,469
Q1 2026Baupost GroupBuy5,8521,275,154$373,301
Q1 2026Yacktman Asset ManagementBuy5,559334,315$97,870,716
Q1 2026Hancock Classic ValueBuy3,854220,176$64,456,524
Q1 2026Tweedy, Browne Co All Funds (US)Buy1,6684,796$1,404,029

Frequently asked questions about ELV activity

  • Which institutional owners are buying ELV?

    Institutional owners buying ELV include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ELV activity?

    "Buy" means an investor increased their reported position in ELV compared to the prior reporting period. This reflects growing exposure to ELEVANCE HEALTH INC (ELV) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ELV increasing?

    Institutional interest in ELV can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.